Claire S. Padgett
Technik-/Wissenschafts-/F&E-Leiter bei REGULUS THERAPEUTICS INC.
Ursprung des Netzwerks ersten Grades von Claire S. Padgett
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.
16
| Extinct | Pharmaceuticals: Major | 16 |
| Subsidiary | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Claire S. Padgett
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SAVARA INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| University of California San Diego | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Chief Executive Officer Chairman | |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | Director of Finance/CFO President Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal General Counsel | |
| University of Massachusetts | College/University | Director/Board Member Doctorate Degree | |
| New York University | College/University | Doctorate Degree Corporate Officer/Principal | |
| RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member President | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Director/Board Member Analyst-Equity | |
Visgenx, Inc.
 Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Biotechnology | Founder Founder | |
American Association for the Advancement of Science
 American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman President | |
| ARTELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Swarthmore College | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Biotechnology | Director/Board Member | |
Petrichor Healthcare Capital Management LP
 Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is an independent private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | Investment Managers | Consultant / Advisor | |
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director/Board Member | |
OS Therapies, Inc.
 OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member | |
| ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chairman | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| SARISSA CAPITAL ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal | |
| Loyola University of Chicago | College/University | Undergraduate Degree | |
| USC Marshall School of Business | College/University | Masters Business Admin | |
| AUSTRALIAN AGRICULTURAL COMPANY LIMITED | Food: Meat/Fish/Dairy | Director/Board Member | |
CovX Research LLC
 CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million. | Biotechnology | Director of Finance/CFO | |
| University of Illinois | College/University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 47 |
| Spanien | 2 |
| Kanada | 2 |
| Vereinigtes Königreich | 2 |
| Australien | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 12 |
| Finance | 7 |
| Commercial Services | 6 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 208 |
| Corporate Officer/Principal | 105 |
| Independent Dir/Board Member | 66 |
| Chairman | 42 |
| President | 40 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peter Greenleaf | 31 |
| Pascale Witz | 31 |
| Ted Love | 31 |
| David Baltimore | 27 |
| Stelios Papadopoulos | 26 |
| William Rastetter | 24 |
| Lewis J. Shuster | 23 |
| Neil Reisman | 23 |
| Jake Nunn | 23 |
| Howard C. Dittrich | 17 |
| Robert Emanuele | 16 |
| Simos Simeonidis | 15 |
| Preston Klassen | 15 |
| Joseph Hagan | 15 |
| Matthew Pauls | 14 |
- Börse
- Insiders
- Claire S. Padgett
- Unternehmensverbindungen
